Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.


6 October 2021 Abstract Presentations

Abstract Presentations
6 October
9:30-11:30 AM ET

September Seminar Registration - Please note the date for the September Virtual Seminar has changed to 6 October. 

Abstract Presenters

Tetsuo Shoda: A Multi-Site Study of Colon Molecular Profiles Establishes Eosinophilic Colitis as a Unique Disease Entity
(10 min, 5 min Q&A)

Netali Ben-Baruch Morgenstern, PhD: Single-cell RNA Sequencing of Mast Cells in Eosinophilic Esophagitis Reveals Local Proliferation and Activation that Persists in Remission
(10 min, 5 min Q&A)

Katrin D. Mayer-Barber, MD: Eosinophils are an integral component of the pulmonary granulocyte response in tuberculosis and promote host resistance in mice
(10 min, 5 min Q&A)

Juliette Tennenbaum, MD: FIP1L1-PDGFRA-associated hypereosinophilic syndrome as a treatable cause of watershed infarction
(3 min)

Rafeul Alam, MDMolecular and Epigenetic Mechanism of Innate Lymphoid Cell (ILC) Memory for Allergen-induced Eosinophilic Asthma
(3 min)

Marwan Hassani, MD: The effect of mepolizumab on eosinophil and basophil kinetics in patients with eosinophilic asthma
(3 min)

Sina Karimi, MD: Mepolizumab efficacy and impact in patients with T cell driven hypereosinophilic syndrome: a biomarker sub-study in the recent placebo-controlled phase III clinical trial
(3 min)

Breakout Rooms
(Abstract presentations - 1 min, followed by discussion with remaining time)

Room 1: GI
Room 2: EOS Biology
Room 3: Asthma and Airways Disease
Room 4: HES and Other Diseases  

Corporate Advisory Council

Allakos             Amgen             AstraZeneca             GSK